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Irradiation, delivered by a synchrotron facility, using a set of highly collimated, narrow and parallel
photon beams spaced by 1 mm or less, has been termed Microbeam Radiation Therapy (MRT). The
tolerance of healthy tissue after MRT was found to be better than after standard broad X-ray beams,
together with a more pronounced response of malignant tissue. The microbeam spacing and transverse
peak-to-valley dose ratio (PVDR) are considered to be relevant biological MRT parameters. We investi-
gated the MRT concept for proton microbeams, where we expected different depth-dose proﬁles and
PVDR dependences, resulting in skin sparing and homogeneous dose distributions at larger beam depths,
due to differences between interactions of proton and photon beams in tissue. Using the FLUKA Monte
Carlo code we simulated PVDR distributions for differently spaced 0.1 mm (sigma) pencil-beams of
entrance energies 60, 80, 100 and 120 MeV irradiating a cylindrical water phantom with and without a
bone layer, representing human head. We calculated PVDR distributions and evaluated uniformity of
target irradiation at distal beam ranges of 60e120 MeV microbeams. We also calculated PVDR distri-
butions for a 60 MeV spread-out Bragg peak microbeam conﬁguration. Application of optimised proton
MRT in terms of spot size, pencil-beam distribution, entrance beam energy, multiport irradiation,
combined with relevant radiobiological investigations, could pave the way for hypofractionation sce-
narios where tissue sparing at the entrance, better malignant tissue response and better dose conformity
of target volume irradiation could be achieved, compared with present proton beam radiotherapy
conﬁgurations.
© 2015 Published by Elsevier Ltd on behalf of Associazione Italiana di Fisica Medica. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The principal aim of radiotherapy is to uniformly irradiate the
target volume with the recommended dose while sparing the
adjacent healthy tissues and critical organs. In microbeam radiation
therapy (MRT), the tumour is irradiated with closely spaced narrow
photon microbeams of high intensity which locally deliver a high
dose to the tissue [1]. The biological advantages of this unique
technique appear to stem from better regeneration of the micro-
vascular structure of the irradiated healthy tissues outside the
direct paths of the microbeams (i.e. within the “dose valleys” be-
tween them) and from the dose-volume effect, both of which
improve the healthy versus malignant tissue response [1,2]. The
microbeam spacing and the peak-to-valley-dose-ratio (PVDR) areM. Kłodowska).
alf of Associazione Italiana di Fisicbelieved to be important factors in this technique. With high
enough PVDR values, tissue recovery at local doses up to several
hundred Gy was achieved, offering a possibility of better local
tumour control in comparison with conventional broad photon
beam techniques [1,2].
An alternative technique to conventional MV X-ray radiotherapy
is that performed with beams of protons or carbon ions. Charged
particles, apart from distal dose enhancement due to the Bragg
Peak (BP), have a well-deﬁned energy-dependent range. The latter
allows one to considerably limit the absorbed dose to healthy tis-
sues and to critical structures located behind the target. By now,
some 40 particle therapy centres operate worldwide, and over
120,000 patients have been treated. Active beam scanning is to-
day's state of the art in proton therapy. Intensity Modulated Proton
Radiotherapy (IMPT) using active beam scanning enables the best
possible coverage of target volume to be achieved, minimizing the
dose to healthy tissue, including dose to the skin. Here, a narrow
proton beam is scanned over each plane transverse to the centrala Medica. This is an open access article under the CC BY-NC-ND license (http://
Figure 1. The proton microbeam diagonal square lattice irradiation pattern, indicating
the deﬁnition of lateral centre-to centre (c-t-c) distances used in this work. An
entrance irradiation ﬁeld of 2  2 cm2 was composed of microbeams arranged ac-
cording to this pattern, with c-t-c distances ranging between 1 and 8 mm.
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varying the entrance energy of the beam) to cover the target vol-
ume. The beam may be delivered from different gantry angles, and
inverse-planned to realise an individually optimised treatment
plan whereby the required beam spot scanning sequence is
implemented by suitably selecting ion ﬂuences and their entrance
energies at different gantry angles, to achieve the required dose
distribution over the target volume.
The MRT principle, originally developed for photon microbeams
can also be applied using narrowly collimated and closely spaced
proton beams [3,4]. Zlobinskaya et al. [4] proposed microchannel
diameters ranging between 50 mm and 500 mm and suggested the
distance between the channels (point-to-point distance, d) to be at
least 10 times larger than the microchannel radius. The proton
pencil microbeam approach could then potentially offer the
advantage of higher tissue tolerance, combined with well-deﬁned
proton ranges closely tailored to the tumour geometry. They next
demonstrated the potential effect of healthy tissue sparing at skin
depth in an experiment using 20 MeV protons of the Munich
Superconducting Nanoscope for Applied nuclear (Kern-) physics
Experiments SNAKE, where the beam was focused to a beam spot
diameter of 500 nm (FWHM), or smaller [5]. Cultured EpiDermFT
skinwas irradiated with a square channel pattern of 10 10 mm2 or
50  50 mm2 to an average dose of 2 Gy (with local dose values of
some 5000 Gy and 200 Gy, respectively), producing a signiﬁcantly
decreased skin inﬂammation response compared to a
homogeneous 2 Gy broad beam proton irradiation of a similar skin
sample [4]. Following the experience with X-ray microbeams, the
importance of peak-to-valley-dose-ratio (PVDR) in proton micro-
beam irradiation was also stated [3,4].
Unlike in X-ray MRT, due to proton scattering, the adjoining
micro-beams will blur with increasing beam depths, possibly
leading to a laterally uniform dose distribution delivered to the
target at Bragg peak (BP) depths. Thus, the beam energy- and
microchannel spacing-dependent PVDR distributions need to be
carefully studied to best exploit the potential advantages of proton
microbeams, which consist in sparing tissues (skin or bone) at
beam entry (related to high PVDR values) and at the same time
achieving homogeneous irradiation at target (BP) depths. This is the
main conceptual difference between proton and X-ray MRT,
where parallel microbeams merely transverse the target volume.
A calculation by Zlobinskaya et al. [4], who used the CERR
open-source planning system and a semi-empirical proton dose
algorithm, demonstrated qualitatively that the concept of proton
microchannel irradiation is realistic. As shown by Prezado and Fois
[3], Monte Carlo methods, commonly used in particle therapy, e.g.
for therapy planning and dose veriﬁcation, can be employed to
investigate the proton microbeam concept.
The general aim of this study was to investigate quantitatively
whether it would indeed be possible to achieve a uniform trans-
verse dose distribution over the target volume in a realistic proton
microbeam irradiation set up and, at the same time, exploit its
advantage in sparing healthy tissues (including, e.g. the skin or
skull bone) at beam entry. We applied the FLUKA Monte Carlo
transport code [6,7] to study the variation of PVDR between their
maximum values at the entrance region and their decrease at
greater depths for a proton beam, while achieving a uniform dose
distribution at target depths (up to 11 cm in water), for different
microchannel distances and microbeam energies. We selected
realistic microbeam parameters (in terms of size and distances) for
initial proton energies ranging between 60 MeV and 120 MeV and
also simulated a spread-out Bragg peak (SOBP) conﬁguration for a
60 MeV proton beam, to verify the selected beam parameters. We
studied the PVDR and depth-dose distributions in a cylindrical
water phantom representing the human head and thehomogeneity of irradiation of a small target volume inside the
phantom. Additional bone layer was also simulated as an outer
phantom layer to examine its impact on PVDR distributions. While
our study using the FLUKA transport code was limited to the
analysis of the dosimetry aspects of proton microbeam radio-
therapy (basically via PVDR distributions and homogeneity of
target irradiation), we believe it to be also relevant to the radiobi-
ology issues of proton MRT.Methods
The FLUKA Monte Carlo (MC) multi-particle transport code ver.
2011.2 has been widely used in particle therapy for dose calcula-
tions, plan veriﬁcation and detector response simulations [7]. To
perform sufﬁciently accurate micro-scale calculations, we set the
parameters in the hadron therapy version of this code to limit
particle transport to 100 keV, to follow neutron transport down to
thermal energies, scattered photons down to 1 keV, and set the
delta ray production threshold at 100 keV. All calculations were run
in parallel mode, to at least 105 protons per spot, for the uncertainty
level not to exceed 2%.
The FLUKA SOURCE routine was adjusted to follow the active
beam scanning method for proton delivery. A pencil beam with a
Gaussian transverse proﬁle of 100 mm (1 sigma) was set up.
Following the X-ray microbeam experience [2], we selected this
beam parameter as being not too unrealistic in any future technical
implementation and not too large to affect the healthy tissue
locally.
To simulate the geometry of the human head, a cylindrical
phantom composed of liquid water was deﬁned, of 16 cm length
and a diameter of 16 cm [8]. Monte Carlo simulations were per-
formed for 100 mm proton microbeams of initial energies of 60, 80,
100 and 120 MeV, each with a 1% full-width-half-maximum
(FWHM) Gaussian energy spread. The lateral centre-to-centre (c-
t-c) pencil-beam distances were varied between 1mm and 8mm in
a diagonal lattice pattern (Fig.1).We have veriﬁed in an initial study
that this diagonal square lattice offers better target volume
coverage than the upright square lattice microbeam pattern used
by other authors [1e4]. Therefore the c-t-c distance quoted in this
work refers to lateral beam separation. To obtain the closest pencil
beam separation distance for a diagonal lattice, our c-t-c value
Table 1
Values of peak-to-valley dose ratios (PVDR) calculated for a 60 MeV proton micro-
beam conﬁgurationwith c-t-c distance of 1 mm, calculated at different depths using
vertical voxel sizes of 250 mm or 500 mm. In further calculations, for reasons of
symmetry, vertical voxel sizes of one-half of the c-t-c distances were always used
(see text).
Depth in phantom [mm] Water phantom Water-bone phantom
250 mm 500 mm 250 mm 500 mm
5.0 140.7 ± 9.2 32.0 ± 0.8 77.7 ± 3.8 20.8 ± 0.5
10.0 19.0 ± 0.5 7.2 ± 0.1 6.0 ± 0.1 3.4 ± 0.1
15.0 2.4 ± 0.1 1.8 ± 0.1 1.3 ± 0.1 1.2 ± 0.1
20.0 1.1 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1
25.0 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1




=2. The microbeam beam axes
were parallel to each other and to the axis of the cylinder. The ﬁeld
size of 2  2 cm2 was selected to simulate irradiation of a relatively
small tumour inside this phantom.
To study the effect of proton scattering due to an outer bone
layer (representing the skull bone) in the phantom, calculations
were also performed in the same phantom to which a 0.5 cm thick
layer of compact bone (based on ICRU tissue composition, as given
by the FLUKAmaterial data base [9]), was added, as shown in Fig. 2.
To maintain the same beam ranges inside such a phantom, the
beam entrance energies were increased to 63.5, 83.0, 102.6 and
122.3 MeV, respectively. Again, calculations were then performed
in this phantom, for c-t-c distances, ranging between 1 mm and
8 mm.
In our PVDR calculations, local dose was deﬁned as the sum of
energy deposition events within voxels of a predeﬁned size
(10 mm  500 mm, in horizontal and longitudinal beam directions,
respectively). While recognising that choice of the third (vertical)
dimension of this voxel may strongly inﬂuence PVDR values
calculated along the beam depth, for reasons of symmetry, we al-
ways took the vertical voxel dimension to be one-half of the current
c-t-c distance (e.g., 500 mm being one-half of the 1 mm c-t-c dis-
tance). The effect of selection of 250 mm or 500 mm as the vertical
voxel dimension on the calculated PVDR values with depth, for a
60 MeV proton beam calculation with c-t-c distance of 1 mm, is
shown in Table 1. The calculated dose in each voxel was normalised
to the dose per one incident proton. To extract the PVDR values,
cross proﬁles were calculated at steps of 5 mm depth in the
phantom, in voxels of aforementioned sizes.
We described the homogeneity of dose deposition in the target
volume (at the depth of the Bragg peak or within the range of the
spread-out Bragg peak) by the ratio between the minimum dose,
Dmin, and maximum dose Dmax, (expressed in percent), choosing
Dmin/Dmax > 95% as the criterion of homogeneity, to reﬂect the spirit
of ICRU recommendations [10,11]. We tested this criterion over the
central 1 1 cm2 part of the 2 2 cm2 ﬁeld used in our calculations.
To further study themicrochannel concept in an extended target
volume over the range of the SOBP, we simulated a suitable
composition of proton beams of energies between 40 and
60 MeV in steps of 2 MeV (for the “bone phantom”:
43.5e63.5 MeV, respectively) with a 1 mm lateral c-t-c distance
between the pencil beams. Local and global dose distributions
were compared with that calculated for the Bragg peak produced
by a 60 MeV microchannel proton beam.Figure 2. Design of head phantoms used in this work: in the water-bone phantom, a
5 mm thick outer layer of ICRU bone composition was added without changing the
dimensions of the water phantom.Results and discussion
To exemplify the particular aspects of themicrobeam irradiation
technique we note that, in the case e.g. of 60 MeV pencil proton
microbeams (1 s ¼ 100 um) entering the medium (water) with a c-
t-c distance of 1 mm, 86% of these protons will travel in narrow
channels of diameter 4 s (0.4 mm), which constitute about 22% of
the entrance plane. If the c-t-c distance is increased to 2 mm ac-
cording to the pattern shown in Fig. 1, the percentage of the irra-
diated volume at this plane decreases to 5.4%. Consequently, the
fraction of irradiated skin cells will decrease with increasing c-t-c
distances and ﬂuences (and corresponding local doses) across the
entrance ﬁeld within each micro-channel will be higher by re-
ciprocals of these percentages.
We wished ﬁrst to study the conditions at which transverse
homogeneity may be achieved at target depth, i.e. at the depth of
the Bragg peak (BP). Figure 3 shows the result of a systematic
calculation of uniformity of dose coverage at respective BP depths
in the water phantom for beams of energies ranging from 60 to
120 MeV, and c-t-c distances from 1 to 8 mm. To obtain homoge-
neity better than 90% at the highest considered beam energy
(120MeV), the c-t-c distances should not exceed 6mm. At 100MeV
beam energy somewhat poorer homogeneity can still be achieved
for c-t-c values ranging between 3 and 5 mm, and at 80 MeV e for
c-t-c values of 3 mm or less. In the case of the lowest beam energy
(60 MeV), it is possible to fulﬁl the 95% homogeneity criterion at BPFigure 3. Field dose homogeneity at depths of corresponding Bragg peaks, after irra-
diation of the water-only phantom with proton microbeams (s ¼ 100 mm) of energy
60 MeV, 80 MeV, 100 MeV and 120 MeV, with c-t-c spacing ranging between 1 and
8 mm. The 95% reference level is shown by a dotted line. For clarity, uncertainties of
dose calculation (±2%) are not shown.
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results illustrate the ranges of c-t-c distances and of proton energies
for which uniform dose distribution in the target may be achieved.
In similar calculations performed for the water phantom with
bone layers, dose uniformity was generally improved by some 4% in
most situations, due to higher beam scattering by the 5 mm-thick
entrance bone layer.
Following earlier reports on photon microbeam irradiations
using synchrotron radiation [1,2], we have assumed that protection
of healthy tissues depends on the spatial distribution of the peak-
to-valley dose ratio, PVDR, which characterizes the non-
uniformity between the irradiated and non-irradiated regions.
We therefore calculated the PVDR values in proton microbeams for
c-t-c distances where reasonable dose homogeneity could be ach-
ieved at target (BP) depths. As outlined above, we recognise the
dependence of the calculated PVDR value on the voxel volume (cf.
Table 1), also noting that the calculated value of PVDR does not
scale with voxel volume and depends on depth in phantom (as
shown in Table 1, at larger depths the result is the same for either
voxel volume). Over the entrance region, the smaller is the voxel
volume, the higher is the calculated PVDR value. This is to be ex-
pected, as most of the beam energy is deposited close to its path.
In Table 2 we show results of systematic calculations of PVDR
values at different depths, for beams of entrance energies 60, 80,
100 or 120 MeV in the water-alone or water-with-bone head
phantoms, for c-t-c distances between 1 and 6 mm. In general, in
the water phantom, after a depth of 5 mm the PVDR values
decrease ﬁvefold, while in the water-with-bone phantom they
decrease by a factor of 10. At greater depths the gradual decrease in
PVDR values is roughly by a factor of two per 5 mm step in depth,
for either phantom. In Fig. 4 we illustrate the strong dependence of
PVDR values on c-t-c distances (range: 1e4 mm) at a BP depth of
30 mm for 60 MeV microbeams, in the water phantom. At this
depth, reasonable conformity is obtained with 1 mm c-t-c distance.
Scattering of protons in the microbeams is enhanced as the
atomic number Z of absorber increases, and is less pronounced as
their energy decreases. These effects lead to a broadening of the
initially narrow beam channels with depth in tissue, to a depth at
which PVDR approaches unity, being absorber material-dependent.
This may be seen in Fig. 5, where we show the calculated depth-
dose distribution of relative absorbed dose in the head phantom,
over steps of 5 mm in depth. Addition of a 5 mm-thick ICRU boneFigure 4. Transverse dose distributions of 60 MeV proton microbeams (s ¼ 100 mm)
with c-t-c distances of 1e4 mm, at 30 mm depth in the water phantom, normalised to
their maximum values. For clarity, uncertainties of dose calculation (±2%) are not
shown.layer decreases the initial PVDR by some 30% due to additional
beam spreading by the bonematerial which is denser thanwater. In
the background of this ﬁgure we plotted the total dose distribution
integrated over the entire phantom volume.
We found the entrance values of PVDR at the phantom surface to
be relatively high (between 70 and 7300) and to depend on the
proton entrance energy. Since protons of higher energy produce
more energetic delta-rays, their radial range expands, hence their
corresponding PVDRs at entrance are lower if the same detector
voxel volumes are considered. However, PVDR values for slower
protons decrease more rapidly at increasing depths in the phantom
because of enhanced proton scattering as their energy decreases.
The effect of c-t-c distance variation is therefore highly dependent
on the entrance beam energy, acting only to a depth of about
10 mm for a 60 MeV microbeam set up with a 1 mm lateral c-t-c
distance, and to a depth of some 50 mm for a 120 MeV microbeam
with a c-t-c distance of 6 mm, at which the PVDR value is about 10.
In proton radiotherapy the lateral beam penumbra, P90/10,
characterizes the steepness of the edges of transverse dose distri-
bution proﬁles at given depths, between 90% and 10% dose levels. In
Fig. 6 we show dose proﬁles extracted at BP depths for a set of
microbeams delivering a 2 2 cm2 entrance ﬁeld to thewater-bone
phantom, where the P90/10 values increase from less than 2.5 mm
for a 63.5 MeV microbeam (c-t-c distance of 1 mm) to 6 mm for a
122.3 MeV one (c-t-c distance of 6 mm). In the water phantom, the
ﬁeld ﬂatness and the lateral penumbrae are not very different, at
respective entrance microbeam energies and distances (results not
shown). Clearly, for such small target volumes any proton micro-
beam proﬁle cannot compete with the sharp penumbrae of photon
MRT beams [1,2] as, in tissue, 100 keV X-rays are mainly absorbed
rather than scattered.
To evaluate PVDR distributions at different depths in a spread-
out Bragg peak conﬁguration, we performed a rough SOBP calcu-
lation for proton beams with adjusted ﬂuence weighting. The
entrance energies of these beams, with c-t-c separation of 1 mm,
ranged between 40 and 60 MeV in 2 MeV steps. We aimed at
achieving SOBP modulation of 1.6 cm, and simulated a 1  1 cm2
ﬁeld in the water or water-bone phantoms. The result is illustrated
in Fig. 7. This microbeam separation distance was sufﬁcient to
achieve conformal and uniform dose coverage of the distal target
region in a 60 MeV proton beam. At lower beam energies, however,
the 1 mm c-t-c distance was too large to achieve uniformity,
resulting in considerable dose variation within the target volume
(up to 15%). Thus, in principle, SOBP microbeam irradiation is
feasible, also for multiple ﬁelds [4]. However, achieving uniform
dose distribution within the SOBP of proton microbeams requires a
trade-off between larger centre-to-centre distances of the pencil
beams (resulting in higher PVDR values at larger depths) and dose
uniformity within the treatment volume. As the latter also strongly
depends on the beam range, a sophisticated tool would need to be
developed to achieve an acceptable optimised SOBP treatment
plan.
The biological processes underlying microbeam radiotherapy
are not well understood. The sparing effect of microscopic beams in
normal tissue is believed to be connected with rapid regeneration
of microvessels in the irradiated tissue cells outside the microbeam
paths (i.e. in the “valleys” of the transversal dose distributions),
hence the importance of the PVDR) [1,2]. It is not clear to what
extent the increasing values of dose at the “valleys” with beam
depths observed in our proton microbeam simulations are biolog-
ically signiﬁcant. Another mechanism to consider is microbeam
damage to the network of microvessels surrounding the tumour
which could lead to tumour tissue necrosis due to loss of blood
perfusion. The response of the microvasculature of normal tissues
and that of the tumour to high local doses may differ, the latter
Table 2
Values of peak-to-valley dose ratios (PVDR) evaluated in steps of 10 mm depth in the water-only phantom (top) and the water-with-bone phantom (bottom), for proton
microbeams (s ¼ 100 mm) of different entrance energy and c-t-c distances. Empty entries in these tables represent PVDR values of 1 till the corresponding BP depth.
Depth in phantom [mm] Centre-to-centre distance
1 mm 3 mm 5 mm 6 mm
Water phantom 60 MeV 80 MeV 100 MeV 120 MeV
5.0 32.0 ± 0.9 480.6 ± 34.6 1019.6 ± 20.7 1229.7 ± 49.3
15.0 1.8 ± 0.1 98.1 ± 6.0 267.4 ± 16.9 372.9 ± 11.5
25.0 1.0 ± 0.1 14.6 ±0.4 92.7 ± 5.9 155.4 ± 7.1
35.0 2.6 ± 0.1 30.3 ± 1.2 70.8 ± 1.8
45.0 1.1 ± 0.1 8.4 ± 0.3 28.9 ± 1.2
55.0 2.9 ± 0.1 10.5 ± 0.3
65.0 1.4 ± 0.1 4.3 ± 0.1
75.0 1.0 ± 0.1 2.2 ± 0.1
85.0 1.4 ± 0.1
95.0 1.1 ± 0.1
Water-bone phantom 63.5 MeV 83.0 MeV 102.6 MeV 122.3 MeV
5.0 20.8 ± 0.5 346.6 ± 22.4 781.1 ± 37.8 916.2 ± 9.7
15.0 1.2 ± 0.1 57.7 ± 3.7 178.9 ± 11.9 268.8 ± 3.5
25.0 1.0 ± 0.1 7.3 ± 0.2 63.2 ± 3.1 112.7 ± 6.3
35.0 1.8 ± 0.1 18.2 ± 0.6 50.3 ± 1.6
45.0 1.0 ± 0.1 5.4 ± 0.1 18.8 ± 0.6
55.0 2.2 ± 0.1 7.1 ± 0.1
65.0 1.2 ± 0.1 3.2 ± 0.1
75.0 1.0 ± 0.1 1.8 ± 0.1
85.0 1.2 ± 0.1
95.0 1.0 ± 0.1
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the enhanced therapeutic effect of themicrobeams [3]. The effect of
the microbeam on the skin may also be related to the size of the
irradiated area and the ionization density of the microbeam radi-
ation, as observed via skin erythema or ulceration of pig skin
irradiated by small sources [12].
It is not clear towhat extent our results obtained for protonMRT
can be interpreted via photon MRT investigations [1,2]. According
to our PVDR calculations, any beneﬁt from the peak-and-valley
shape of the lateral dose distribution would be effective only over
the ﬁrst 25e35 mm in depth, for proton microbeams of entrance
energies ranging between 60 and 120 MeV. Beyond those depths,
we should expect no difference between standard proton therapy
and the micro-beam method as the dose distribution is relativelyFigure 5. Depth dose distributions for a set of proton microbeams (s ¼ 100 mm, c-t-
c ¼ 1 mm) forming a 1  1 cm2 entrance ﬁeld for a 60 MeV beam entering axially the
water-only (red) or water-with-bone (black) head phantoms. These dose distributions
are normalised to their maxima at BP depth. In the background the total dose inte-
grated over the entire phantom volume is plotted. For clarity, uncertainties of dose
calculation (± 2%) are not shown. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)uniform. When considering skull irradiation in children, where a
high entrance dose could lead to undesired late effects (such as
bone malformation), in the proton microbeam approach one could
perhaps decrease the irradiated volume by limiting the spot
number and increasing the spot distances. Also, further optimisa-
tion of the number and entrance energies of microbeam ports could
be considered. Such a complex approach to beam optimisation will
not, however, be possible without relevant radiobiological data
which could address the effect of the entrance dose reduction and
tumour response in proton MRT. Application of a well optimized
irradiation scheme, in terms of spot size and distribution, entrance
beam energy, or number of ports, combined with such
radiobiological investigations, could then pave the way forFigure 6. Lateral dose proﬁles in the water-with-bone phantom for a set of proton
microbeams (s ¼ 100 mm) forming a 2  2 cm2 entrance ﬁeld, calculated for different
beam entrance energies and c-t-c separation, at respective Bragg peak depths in
phantom: 30 mm (63.5 MeV, c-t-c 1 mm), 51 mm (83.0 MeV, c-t-c 3 mm), 76,5 mm
(102.6 MeV, c-t-c 5 mm) and 105.5 mm (122.3 MeV, c-t-c 6 mm). Proﬁles are nor-
malised to their maximum values. For clarity, uncertainties of dose calculation (±2%)
are not shown.
Figure 7. Depth dose distributions in the water-with-bone head phantom for a set of
proton microbeams (s ¼ 100 mm, c-t-c ¼ 1 mm) forming a 1  1 cm2 entrance ﬁeld in a
spread-out Bragg peak (SOBP) conﬁguration (blue), and for a pristine pencil beam of
63.5 MeV entrance energy (black). Each distribution is normalised to its respective
value at BP depth. The SOBP conﬁguration was designed to cover a target volume of
1  1  1.6 cm3 with proton beams of maximum energy 63.5 MeV. For beams of lower
energies dose homogeneity inside the SOBP region falls below the 95% level (e.g., it is
85% at 15 mm depth). In the background the total dose integrated over the entire
phantom volume is plotted. For clarity, uncertainties of dose calculation (±2%) are not
shown. (For interpretation of the references to colour in this ﬁgure legend, the reader
is referred to the web version of this article.)
M. Kłodowska et al. / Physica Medica 31 (2015) 621e626626hypofractionation scenarios where lower entrance dose, better
malignant tissue response and better conformity to the target
volume could be achieved, compared with the more common
proton beam radiotherapy procedures.
Conclusions
Microbeam radiation therapy offers potential beneﬁt from high-
dose collimated micro-size photon layers by increasing healthy
tissue recovery together with better local tumour control. The
proposed technique of proton microbeam radiotherapy combines
the advantages of small beam size with proton scattering for target
dose escalation. Active scanning technique could then be used with
a pre-calculated map of spots to take into account the contribution
from the adjacent pencil-beams. The obtained PVDR values are
comparable with photon MRT data over depths of some 15e25 mm
in tissue, especially for protons of entrance energies above
80 MeV [3]. The additional advantage of the proton MRT is in the
well-deﬁned proton range, which is of particular importance, e.g. in
brain radiotherapy. We showed the possibility of beamoptimization by taking into account the beam size, c-t-c distance or
entrance energy of the beam. By combining several ports one could
signiﬁcantly boost the absorbed dose in the target volume e
possibly arriving at a superior method for high-precision PVDR-
mode irradiation, especially for hypofractionation scenarios. None
of these expectations can, however, be fulﬁlled without better
understanding of the involved biology and radiobiology of both
healthy and malignant tissues irradiated by proton microbeams,
nor without the considerable engineering effort to develop inno-
vative techniques of delivering such beams.
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